The Community Guide

- gsearch

Search Results

Narrow Results:

2021 1

Journal Article 1

1 Results

Refine Results

Refine Results:

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021

CITE Title : Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021 Personal Author(s) : Rosenblum, Hannah G.;Hadler, Stephen C.;Moulia, Danielle;Shimabukuro, Tom T.;Su, John R.;Tepper, Naomi K.;Ess, Kevin C.;Woo, Emily Jane;Mba-Jonas, Adamma;Alimchandani, Meghna;Nair, Narayan;Klein, Nicola P.;Hanson, Kayla E.;Markowitz, Lauri E.;Wharton, Melinda;McNally, Veronica V.;Romero, José R.;Talbot, H. Keipp;Lee, Grace M.;Daley, Matthew F.;Mbaeyi, Sarah A.;Oliver, Sara E.; Corporate Authors(s) : United States. Advisory Committee on Immunization Practices.;CDC COVID-19 Response Team.;Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service.;Vanderbilt University School of Medicine.;United States. Food and Drug Administration.;Kaiser Permanente Northern California. Division of Research.;Marshfield Clinic Research Institute.;Franny Strong Foundation (West Bloomfield, Michigan);Arkansas. Department of Arkansas. Department of Health.;Stanford University School of Medicine.;Kaiser Permanente Colorado. Institute for Health Research.; Published Date : August 10, 2021 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2021; v. 70 Early Release URL : https://stacks.cdc.gov/view/cdc/108729 Rosenblum, Hannah G. et al. (2021). Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021. 70 Rosenblum, Hannah G. et al. "Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021" 70 (2021) Rosenblum, Hannah G. et al. "Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021" vol. 70, 2021 Export RIS Citation Information.

:

Rosenblum, Hannah G. ;

Hadler, Stephen C.

August 10, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Rare serious adverse events have been reported after COVID-19 vaccination, including Guillain-Barré syndrome ...

To see more results, try removing search filters or changing the search terms